医薬品温度管理包装の世界市場レポート2025-2031

QY Research > レポート一覧 > パッケージ業界 > 医薬品温度管理包装の世界市場レポート2025-2031

英文タイトル： Global Temperature Controlled Package for Pharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1558010
発表時期：2025-08-08
訪問回数：31
ページ数：180
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：181
レポートカテゴリ：パッケージ業界

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、医薬品温度管理包装の世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別に医薬品温度管理包装市場を分類しています。

本レポートでは、世界の医薬品温度管理包装市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートは医薬品温度管理包装の主要生産者を調査するとともに、主要地域や国の消費状況も提供します。医薬品温度管理包装の主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
Cencora
Skycell
Va-Q-tec AG
Sofrigam SA Ltd.
American Aerogel Corporation
EcoCool GmbH
Aeris Group
Dokasch
HAZGO
Beijing Roloo Technology
Insulated Products Corporation
Inmark Packaging
Guangzhou CCTS
Exeltainer SL
Cool Pac
Cryo Store
Biocair Customs
UPS

タイプ別市場セグメント：
Single Use
Reusable

用途別市場セグメント：
Temperature-Sensitive Pharmaceuticals
Vaccines
Blood Product
Others

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界の医薬品温度管理包装市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて医薬品温度管理包装市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）の医薬品温度管理包装生産量、成長率、市場シェアを調査しています。
二. 消費面では、医薬品温度管理包装の売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーの医薬品温度管理包装売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界の医薬品温度管理包装市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本医薬品温度管理包装レポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：医薬品温度管理包装レポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：医薬品温度管理包装の世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：医薬品温度管理包装の現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：医薬品温度管理包装メーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：医薬品温度管理包装の下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：医薬品温度管理包装のグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米における医薬品温度管理包装市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州における医薬品温度管理包装市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域の医薬品温度管理包装市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米における医薬品温度管理包装市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域の医薬品温度管理包装市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：医薬品温度管理包装の主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：医薬品温度管理包装のサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：医薬品温度管理包装の市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Temperature Controlled Package for Pharmaceutical market is projected to grow from US$ 6030 million in 2024 to US$ 10860 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications.

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain.

The Pharmaceuticals Temperature Controlled Packaging market is primarily driven by the growing demand for biologics, vaccines, and other temperature-sensitive drugs. These medications require strict temperature regulation to maintain their efficacy and safety, which has led to an increased focus on reliable and efficient packaging solutions. With the rise in global distribution of pharmaceuticals, particularly driven by COVID-19 vaccines and other biologic treatments, the need for advanced temperature-controlled packaging systems has surged, ensuring products maintain their required temperature during transit.

One of the key challenges for this market is the high cost associated with temperature-controlled packaging systems. The materials, technologies, and infrastructure required to ensure proper thermal insulation and monitoring of temperature-sensitive drugs are expensive, which can increase the overall cost of the pharmaceutical supply chain. Smaller companies and those operating in developing regions often struggle to afford such sophisticated packaging solutions, which can limit the accessibility of critical medicines.

The market also faces growing regulatory and environmental pressures. Stringent guidelines from regulatory bodies like the FDA and EMA require adherence to specific standards for packaging used in transporting pharmaceuticals. Additionally, there is increasing scrutiny on the environmental impact of these packaging materials, as many of them are non-recyclable or have a high carbon footprint. Balancing regulatory compliance with sustainability concerns poses a significant challenge for manufacturers in the sector.

There are lot of market players in the global Pharmaceuticals Temperature Controlled Packaging market, thus it’s tremendously fragmented. The large firms face hurdles as a result of high market fragmentation, which prevents them from growing into other markets or countries.

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Temperature Controlled Package for Pharmaceutical market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
Cencora
Skycell
Va-Q-tec AG
Sofrigam SA Ltd.
American Aerogel Corporation
EcoCool GmbH
Aeris Group
Dokasch
HAZGO
Beijing Roloo Technology
Insulated Products Corporation
Inmark Packaging
Guangzhou CCTS
Exeltainer SL
Cool Pac
Cryo Store
Biocair Customs
UPS

Segment by Type
Single Use
Reusable

Segment by Application
Temperature-Sensitive Pharmaceuticals
Vaccines
Blood Product
Others

Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA

Chapter Outline
Chapter 1: Defines the Temperature Controlled Package for Pharmaceutical study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Temperature Controlled Package for Pharmaceutical: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Temperature Controlled Package for Pharmaceutical Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Use
1.2.3 Reusable
1.3 Market Segmentation by Application
1.3.1 Global Temperature Controlled Package for Pharmaceutical Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Temperature-Sensitive Pharmaceuticals
1.3.3 Vaccines
1.3.4 Blood Product
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Temperature Controlled Package for Pharmaceutical Revenue Estimates and Forecasts 2020-2031
2.2 Global Temperature Controlled Package for Pharmaceutical Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
3.1 Global Temperature Controlled Package for Pharmaceutical Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Temperature Controlled Package for Pharmaceutical Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single Use Market Size by Players
3.3.2 Reusable Market Size by Players
3.4 Global Temperature Controlled Package for Pharmaceutical Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
4.1 Global Temperature Controlled Package for Pharmaceutical Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats

5 Global Downstream Application Analysis
5.1 Global Temperature Controlled Package for Pharmaceutical Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Temperature Controlled Package for Pharmaceutical Market Size by Type (2020-2031)
6.4 North America Temperature Controlled Package for Pharmaceutical Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Temperature Controlled Package for Pharmaceutical Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico

7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Temperature Controlled Package for Pharmaceutical Market Size by Type (2020-2031)
7.4 Europe Temperature Controlled Package for Pharmaceutical Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Temperature Controlled Package for Pharmaceutical Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size by Type (2020-2031)
8.4 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Temperature Controlled Package for Pharmaceutical Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Temperature Controlled Package for Pharmaceutical Market Size by Type (2020-2031)
9.4 Central and South America Temperature Controlled Package for Pharmaceutical Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Temperature Controlled Package for Pharmaceutical Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Temperature Controlled Package for Pharmaceutical Market Size by Type (2020-2031)
10.4 Middle East and Africa Temperature Controlled Package for Pharmaceutical Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Temperature Controlled Package for Pharmaceutical Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa

11 Corporate Profile
11.1 Sonoco Products Company
11.1.1 Sonoco Products Company Corporation Information
11.1.2 Sonoco Products Company Business Overview
11.1.3 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.1.4 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.1.5 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Revenue by Product in 2024
11.1.6 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Revenue by Application in 2024
11.1.7 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Revenue by Geographic Area in 2024
11.1.8 Sonoco Products Company Temperature Controlled Package for Pharmaceutical SWOT Analysis
11.1.9 Sonoco Products Company Recent Developments
11.2 Envirotainer
11.2.1 Envirotainer Corporation Information
11.2.2 Envirotainer Business Overview
11.2.3 Envirotainer Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.2.4 Envirotainer Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.2.5 Envirotainer Temperature Controlled Package for Pharmaceutical Revenue by Product in 2024
11.2.6 Envirotainer Temperature Controlled Package for Pharmaceutical Revenue by Application in 2024
11.2.7 Envirotainer Temperature Controlled Package for Pharmaceutical Revenue by Geographic Area in 2024
11.2.8 Envirotainer Temperature Controlled Package for Pharmaceutical SWOT Analysis
11.2.9 Envirotainer Recent Developments
11.3 Pelican Biothermal
11.3.1 Pelican Biothermal Corporation Information
11.3.2 Pelican Biothermal Business Overview
11.3.3 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.3.4 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.3.5 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Revenue by Product in 2024
11.3.6 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Revenue by Application in 2024
11.3.7 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Revenue by Geographic Area in 2024
11.3.8 Pelican Biothermal Temperature Controlled Package for Pharmaceutical SWOT Analysis
11.3.9 Pelican Biothermal Recent Developments
11.4 Cryopak
11.4.1 Cryopak Corporation Information
11.4.2 Cryopak Business Overview
11.4.3 Cryopak Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.4.4 Cryopak Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.4.5 Cryopak Temperature Controlled Package for Pharmaceutical Revenue by Product in 2024
11.4.6 Cryopak Temperature Controlled Package for Pharmaceutical Revenue by Application in 2024
11.4.7 Cryopak Temperature Controlled Package for Pharmaceutical Revenue by Geographic Area in 2024
11.4.8 Cryopak Temperature Controlled Package for Pharmaceutical SWOT Analysis
11.4.9 Cryopak Recent Developments
11.5 DS Smith Pharma
11.5.1 DS Smith Pharma Corporation Information
11.5.2 DS Smith Pharma Business Overview
11.5.3 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.5.4 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.5.5 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Revenue by Product in 2024
11.5.6 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Revenue by Application in 2024
11.5.7 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Revenue by Geographic Area in 2024
11.5.8 DS Smith Pharma Temperature Controlled Package for Pharmaceutical SWOT Analysis
11.5.9 DS Smith Pharma Recent Developments
11.6 Cold Chain Technologies
11.6.1 Cold Chain Technologies Corporation Information
11.6.2 Cold Chain Technologies Business Overview
11.6.3 Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.6.4 Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.6.5 Cold Chain Technologies Recent Developments
11.7 Intelsius
11.7.1 Intelsius Corporation Information
11.7.2 Intelsius Business Overview
11.7.3 Intelsius Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.7.4 Intelsius Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.7.5 Intelsius Recent Developments
11.8 CSafe
11.8.1 CSafe Corporation Information
11.8.2 CSafe Business Overview
11.8.3 CSafe Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.8.4 CSafe Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.8.5 CSafe Recent Developments
11.9 Softbox Systems
11.9.1 Softbox Systems Corporation Information
11.9.2 Softbox Systems Business Overview
11.9.3 Softbox Systems Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.9.4 Softbox Systems Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.9.5 Softbox Systems Recent Developments
11.10 Cencora
11.10.1 Cencora Corporation Information
11.10.2 Cencora Business Overview
11.10.3 Cencora Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.10.4 Cencora Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Skycell
11.11.1 Skycell Corporation Information
11.11.2 Skycell Business Overview
11.11.3 Skycell Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.11.4 Skycell Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.11.5 Skycell Recent Developments
11.12 Va-Q-tec AG
11.12.1 Va-Q-tec AG Corporation Information
11.12.2 Va-Q-tec AG Business Overview
11.12.3 Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.12.4 Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.12.5 Va-Q-tec AG Recent Developments
11.13 Sofrigam SA Ltd.
11.13.1 Sofrigam SA Ltd. Corporation Information
11.13.2 Sofrigam SA Ltd. Business Overview
11.13.3 Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.13.4 Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.13.5 Sofrigam SA Ltd. Recent Developments
11.14 American Aerogel Corporation
11.14.1 American Aerogel Corporation Corporation Information
11.14.2 American Aerogel Corporation Business Overview
11.14.3 American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.14.4 American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.14.5 American Aerogel Corporation Recent Developments
11.15 EcoCool GmbH
11.15.1 EcoCool GmbH Corporation Information
11.15.2 EcoCool GmbH Business Overview
11.15.3 EcoCool GmbH Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.15.4 EcoCool GmbH Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.15.5 EcoCool GmbH Recent Developments
11.16 Aeris Group
11.16.1 Aeris Group Corporation Information
11.16.2 Aeris Group Business Overview
11.16.3 Aeris Group Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.16.4 Aeris Group Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.16.5 Aeris Group Recent Developments
11.17 Dokasch
11.17.1 Dokasch Corporation Information
11.17.2 Dokasch Business Overview
11.17.3 Dokasch Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.17.4 Dokasch Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.17.5 Dokasch Recent Developments
11.18 HAZGO
11.18.1 HAZGO Corporation Information
11.18.2 HAZGO Business Overview
11.18.3 HAZGO Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.18.4 HAZGO Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.18.5 HAZGO Recent Developments
11.19 Beijing Roloo Technology
11.19.1 Beijing Roloo Technology Corporation Information
11.19.2 Beijing Roloo Technology Business Overview
11.19.3 Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.19.4 Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.19.5 Beijing Roloo Technology Recent Developments
11.20 Insulated Products Corporation
11.20.1 Insulated Products Corporation Corporation Information
11.20.2 Insulated Products Corporation Business Overview
11.20.3 Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.20.4 Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.20.5 Insulated Products Corporation Recent Developments
11.21 Inmark Packaging
11.21.1 Inmark Packaging Corporation Information
11.21.2 Inmark Packaging Business Overview
11.21.3 Inmark Packaging Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.21.4 Inmark Packaging Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.21.5 Inmark Packaging Recent Developments
11.22 Guangzhou CCTS
11.22.1 Guangzhou CCTS Corporation Information
11.22.2 Guangzhou CCTS Business Overview
11.22.3 Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.22.4 Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.22.5 Guangzhou CCTS Recent Developments
11.23 Exeltainer SL
11.23.1 Exeltainer SL Corporation Information
11.23.2 Exeltainer SL Business Overview
11.23.3 Exeltainer SL Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.23.4 Exeltainer SL Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.23.5 Exeltainer SL Recent Developments
11.24 Cool Pac
11.24.1 Cool Pac Corporation Information
11.24.2 Cool Pac Business Overview
11.24.3 Cool Pac Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.24.4 Cool Pac Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.24.5 Cool Pac Recent Developments
11.25 Cryo Store
11.25.1 Cryo Store Corporation Information
11.25.2 Cryo Store Business Overview
11.25.3 Cryo Store Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.25.4 Cryo Store Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.25.5 Cryo Store Recent Developments
11.26 Biocair Customs
11.26.1 Biocair Customs Corporation Information
11.26.2 Biocair Customs Business Overview
11.26.3 Biocair Customs Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.26.4 Biocair Customs Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.26.5 Biocair Customs Recent Developments
11.27 UPS
11.27.1 UPS Corporation Information
11.27.2 UPS Business Overview
11.27.3 UPS Temperature Controlled Package for Pharmaceutical Product Features and Attributes
11.27.4 UPS Temperature Controlled Package for Pharmaceutical Revenue and Gross Margin (2020-2025)
11.27.5 UPS Recent Developments

12 Temperature Controlled Package for PharmaceuticalIndustry Chain Analysis
12.1 Temperature Controlled Package for Pharmaceutical Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Temperature Controlled Package for Pharmaceutical Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Temperature Controlled Package for Pharmaceutical Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Temperature Controlled Package for Pharmaceutical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Temperature Controlled Package for Pharmaceutical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Temperature Controlled Package for Pharmaceutical Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Temperature Controlled Package for Pharmaceutical Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Temperature Controlled Package for Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Temperature Controlled Package for Pharmaceutical Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Temperature Controlled Package for Pharmaceutical by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Temperature Controlled Package for Pharmaceutical as of 2024)
 Table 11. Global Temperature Controlled Package for Pharmaceutical Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Temperature Controlled Package for Pharmaceutical Companies Headquarters
 Table 13. Global Temperature Controlled Package for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Temperature Controlled Package for Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Temperature Controlled Package for Pharmaceutical Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Temperature Controlled Package for Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Temperature Controlled Package for Pharmaceutical Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Temperature Controlled Package for Pharmaceutical High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Temperature Controlled Package for Pharmaceutical Growth Accelerators and Market Barriers
 Table 25. North America Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Temperature Controlled Package for Pharmaceutical Growth Accelerators and Market Barriers
 Table 27. Europe Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Temperature Controlled Package for Pharmaceutical Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Temperature Controlled Package for Pharmaceutical Investment Opportunities and Key Challenges
 Table 31. Central and South America Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Temperature Controlled Package for Pharmaceutical Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Temperature Controlled Package for Pharmaceutical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Sonoco Products Company Corporation Information
 Table 35. Sonoco Products Company Description and Major Businesses
 Table 36. Sonoco Products Company Product Features and Attributes
 Table 37. Sonoco Products Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Sonoco Products Company Revenue Proportion by Product in 2024
 Table 39. Sonoco Products Company Revenue Proportion by Application in 2024
 Table 40. Sonoco Products Company Revenue Proportion by Geographic Area in 2024
 Table 41. Sonoco Products Company Temperature Controlled Package for Pharmaceutical SWOT Analysis
 Table 42. Sonoco Products Company Recent Developments
 Table 43. Envirotainer Corporation Information
 Table 44. Envirotainer Description and Major Businesses
 Table 45. Envirotainer Product Features and Attributes
 Table 46. Envirotainer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Envirotainer Revenue Proportion by Product in 2024
 Table 48. Envirotainer Revenue Proportion by Application in 2024
 Table 49. Envirotainer Revenue Proportion by Geographic Area in 2024
 Table 50. Envirotainer Temperature Controlled Package for Pharmaceutical SWOT Analysis
 Table 51. Envirotainer Recent Developments
 Table 52. Pelican Biothermal Corporation Information
 Table 53. Pelican Biothermal Description and Major Businesses
 Table 54. Pelican Biothermal Product Features and Attributes
 Table 55. Pelican Biothermal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Pelican Biothermal Revenue Proportion by Product in 2024
 Table 57. Pelican Biothermal Revenue Proportion by Application in 2024
 Table 58. Pelican Biothermal Revenue Proportion by Geographic Area in 2024
 Table 59. Pelican Biothermal Temperature Controlled Package for Pharmaceutical SWOT Analysis
 Table 60. Pelican Biothermal Recent Developments
 Table 61. Cryopak Corporation Information
 Table 62. Cryopak Description and Major Businesses
 Table 63. Cryopak Product Features and Attributes
 Table 64. Cryopak Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Cryopak Revenue Proportion by Product in 2024
 Table 66. Cryopak Revenue Proportion by Application in 2024
 Table 67. Cryopak Revenue Proportion by Geographic Area in 2024
 Table 68. Cryopak Temperature Controlled Package for Pharmaceutical SWOT Analysis
 Table 69. Cryopak Recent Developments
 Table 70. DS Smith Pharma Corporation Information
 Table 71. DS Smith Pharma Description and Major Businesses
 Table 72. DS Smith Pharma Product Features and Attributes
 Table 73. DS Smith Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. DS Smith Pharma Revenue Proportion by Product in 2024
 Table 75. DS Smith Pharma Revenue Proportion by Application in 2024
 Table 76. DS Smith Pharma Revenue Proportion by Geographic Area in 2024
 Table 77. DS Smith Pharma Temperature Controlled Package for Pharmaceutical SWOT Analysis
 Table 78. DS Smith Pharma Recent Developments
 Table 79. Cold Chain Technologies Corporation Information
 Table 80. Cold Chain Technologies Description and Major Businesses
 Table 81. Cold Chain Technologies Product Features and Attributes
 Table 82. Cold Chain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Cold Chain Technologies Recent Developments
 Table 84. Intelsius Corporation Information
 Table 85. Intelsius Description and Major Businesses
 Table 86. Intelsius Product Features and Attributes
 Table 87. Intelsius Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Intelsius Recent Developments
 Table 89. CSafe Corporation Information
 Table 90. CSafe Description and Major Businesses
 Table 91. CSafe Product Features and Attributes
 Table 92. CSafe Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. CSafe Recent Developments
 Table 94. Softbox Systems Corporation Information
 Table 95. Softbox Systems Description and Major Businesses
 Table 96. Softbox Systems Product Features and Attributes
 Table 97. Softbox Systems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Softbox Systems Recent Developments
 Table 99. Cencora Corporation Information
 Table 100. Cencora Description and Major Businesses
 Table 101. Cencora Product Features and Attributes
 Table 102. Cencora Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Cencora Recent Developments
 Table 104. Skycell Corporation Information
 Table 105. Skycell Description and Major Businesses
 Table 106. Skycell Product Features and Attributes
 Table 107. Skycell Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Skycell Recent Developments
 Table 109. Va-Q-tec AG Corporation Information
 Table 110. Va-Q-tec AG Description and Major Businesses
 Table 111. Va-Q-tec AG Product Features and Attributes
 Table 112. Va-Q-tec AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Va-Q-tec AG Recent Developments
 Table 114. Sofrigam SA Ltd. Corporation Information
 Table 115. Sofrigam SA Ltd. Description and Major Businesses
 Table 116. Sofrigam SA Ltd. Product Features and Attributes
 Table 117. Sofrigam SA Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Sofrigam SA Ltd. Recent Developments
 Table 119. American Aerogel Corporation Corporation Information
 Table 120. American Aerogel Corporation Description and Major Businesses
 Table 121. American Aerogel Corporation Product Features and Attributes
 Table 122. American Aerogel Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. American Aerogel Corporation Recent Developments
 Table 124. EcoCool GmbH Corporation Information
 Table 125. EcoCool GmbH Description and Major Businesses
 Table 126. EcoCool GmbH Product Features and Attributes
 Table 127. EcoCool GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. EcoCool GmbH Recent Developments
 Table 129. Aeris Group Corporation Information
 Table 130. Aeris Group Description and Major Businesses
 Table 131. Aeris Group Product Features and Attributes
 Table 132. Aeris Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Aeris Group Recent Developments
 Table 134. Dokasch Corporation Information
 Table 135. Dokasch Description and Major Businesses
 Table 136. Dokasch Product Features and Attributes
 Table 137. Dokasch Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Dokasch Recent Developments
 Table 139. HAZGO Corporation Information
 Table 140. HAZGO Description and Major Businesses
 Table 141. HAZGO Product Features and Attributes
 Table 142. HAZGO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. HAZGO Recent Developments
 Table 144. Beijing Roloo Technology Corporation Information
 Table 145. Beijing Roloo Technology Description and Major Businesses
 Table 146. Beijing Roloo Technology Product Features and Attributes
 Table 147. Beijing Roloo Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Beijing Roloo Technology Recent Developments
 Table 149. Insulated Products Corporation Corporation Information
 Table 150. Insulated Products Corporation Description and Major Businesses
 Table 151. Insulated Products Corporation Product Features and Attributes
 Table 152. Insulated Products Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Insulated Products Corporation Recent Developments
 Table 154. Inmark Packaging Corporation Information
 Table 155. Inmark Packaging Description and Major Businesses
 Table 156. Inmark Packaging Product Features and Attributes
 Table 157. Inmark Packaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Inmark Packaging Recent Developments
 Table 159. Guangzhou CCTS Corporation Information
 Table 160. Guangzhou CCTS Description and Major Businesses
 Table 161. Guangzhou CCTS Product Features and Attributes
 Table 162. Guangzhou CCTS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Guangzhou CCTS Recent Developments
 Table 164. Exeltainer SL Corporation Information
 Table 165. Exeltainer SL Description and Major Businesses
 Table 166. Exeltainer SL Product Features and Attributes
 Table 167. Exeltainer SL Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Exeltainer SL Recent Developments
 Table 169. Cool Pac Corporation Information
 Table 170. Cool Pac Description and Major Businesses
 Table 171. Cool Pac Product Features and Attributes
 Table 172. Cool Pac Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 173. Cool Pac Recent Developments
 Table 174. Cryo Store Corporation Information
 Table 175. Cryo Store Description and Major Businesses
 Table 176. Cryo Store Product Features and Attributes
 Table 177. Cryo Store Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 178. Cryo Store Recent Developments
 Table 179. Biocair Customs Corporation Information
 Table 180. Biocair Customs Description and Major Businesses
 Table 181. Biocair Customs Product Features and Attributes
 Table 182. Biocair Customs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 183. Biocair Customs Recent Developments
 Table 184. UPS Corporation Information
 Table 185. UPS Description and Major Businesses
 Table 186. UPS Product Features and Attributes
 Table 187. UPS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 188. UPS Recent Developments
 Table 189. Raw Materials Key Suppliers
 Table 190. Distributors List
 Table 191. Market Trends and Market Evolution
 Table 192. Market Drivers and Opportunities
 Table 193. Market Challenges, Risks, and Restraints
 Table 194. Research Programs/Design for This Report
 Table 195. Key Data Information from Secondary Sources
 Table 196. Key Data Information from Primary Sources


List of Figures
 Figure 1. Temperature Controlled Package for Pharmaceutical Product Picture
 Figure 2. Global Temperature Controlled Package for Pharmaceutical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single Use Product Picture
 Figure 4. Reusable Product Picture
 Figure 5. Global Temperature Controlled Package for Pharmaceutical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Temperature-Sensitive Pharmaceuticals
 Figure 7. Vaccines
 Figure 8. Blood Product
 Figure 9. Others
 Figure 10. Temperature Controlled Package for Pharmaceutical Report Years Considered
 Figure 11. Global Temperature Controlled Package for Pharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Temperature Controlled Package for Pharmaceutical Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Temperature Controlled Package for Pharmaceutical Revenue Market Share by Region (2020-2031)
 Figure 15. Global Temperature Controlled Package for Pharmaceutical Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Single Use Revenue Market Share by Player in 2024
 Figure 18. Reusable Revenue Market Share by Player in 2024
 Figure 19. Global Temperature Controlled Package for Pharmaceutical Revenue Market Share by Type (2020-2031)
 Figure 20. Global Temperature Controlled Package for Pharmaceutical Revenue Market Share by Application (2020-2031)
 Figure 21. North America Temperature Controlled Package for Pharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) in 2024
 Figure 23. North America Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Temperature Controlled Package for Pharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) in 2024
 Figure 30. Europe Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 33. France Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Temperature Controlled Package for Pharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 45. India Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Temperature Controlled Package for Pharmaceutical Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Temperature Controlled Package for Pharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) in 2024
 Figure 53. Central and South America Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Temperature Controlled Package for Pharmaceutical Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) in 2024
 Figure 59. South America Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Temperature Controlled Package for Pharmaceutical Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Temperature Controlled Package for Pharmaceutical Revenue (2020-2025) & (US$ Million)
 Figure 65. Temperature Controlled Package for Pharmaceutical Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed

以下、関連資料のご紹介